Chemerin inhibits the development of hepatocellular carcinoma (HCC) metastasis via the upregulation of tumor suppressor phosphatase and tensin homolog (PTEN) and by interfering with the PTEN–CMKLR1 interaction. This evidence concerns the gene RARRES2 and hepatocellular carcinoma.